SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-17-050210
Filing Date
2017-08-24
Accepted
2017-08-24 18:36:55
Documents
2
Period of Report
2017-08-22

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1534
2 POA DOCUMENT poa.txt EX-24.3_741641 3029
  Complete submission text file 0001209191-17-050210.txt   6046
Mailing Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121 858-362-6295
ANAPTYSBIO INC (Issuer) CIK: 0001370053 (see all company filings)

IRS No.: 203828755 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANAPTYSBIO, INC. 10421 PACIFIC CENTER COURT, SUITE 200 SAN DIEGO CA 92121
Business Address
Ware J. Anthony (Reporting) CIK: 0001715429 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37985 | Film No.: 171050207